Stifel Maintains Buy on Incyte, Raises Price Target to $157

Stifel analyst Stephen Willey has reaffirmed a Buy rating on Incyte (NASDAQ: INCY) and increased the price target from $145 to $157. This adjustment reflects a positive outlook for the company's performance.